Sign In

Ismene Grohmann

Business Strategy & Commercialization Lead New Analyte Ventures at Abbott

Ismene Grohmann is currently the Chief Product Officer at LIOM.12 She is an experienced product leader with a background in building products and teams.3 Before joining LIOM, she held the position of Head of Product for Abbott's Consumer Biowearables and Director of Innovation for the Diabetes and Nutrition businesses.12 Additionally, she has 15 years of experience in MedTech and consumer health, building and leading global product organizations and launching innovative hardware, software, and service products.1 Grohmann holds an MSc Econ from Philipps-University Marburg.1

Highlights

Feb 10 · liom.com
Team - LIOM
Abbott, Medtronic to integrate CGM system with insulin devices
Aug 7 · prnewswire.com
Abbott Enters Global Partnership to Connect Its World-Leading ...
Aug 7 · stocktitan.net
Abbott Enters Global Partnership to Connect Its World-Leading ...
Jan 5 · biospace.com
Spiden Announces Breakthrough in Non-Invasive Glucose ...
Spiden Announces Breakthrough in Non-Invasive Glucose Monitoring, Adds Key Executive Hires and Secures $15m in ... - Yahoo Canada Finance
Spiden Announces Breakthrough in Non-Invasive Glucose Monitoring, Adds Key Executive Hires and Secur
Abbott unveils Lingo line of sports biosensors based on diabetes ...
May 14 · abbott.com
Rising to the Test, Innovating for the Future | Abbott Newsroom

Related Questions

What are Ismene Grohmann's key achievements at Abbott?
How did Ismene Grohmann contribute to the development of Abbott's Lingo line?
What is Ismene Grohmann's background in MedTech and consumer health?
What innovative products has Ismene Grohmann successfully launched?
How does Ismene Grohmann's role at New Analyte Ventures impact Abbott's strategy?
Ismene Grohmann
Ismene Grohmann, photo 1
Ismene Grohmann, photo 2
Add to my network

Location

San Francisco, California